We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more
Berkshire Hathaway (NYSE:BRK.A), Chubb (NYSE:CB) – Chubb’s stock increased by approximately 9.3% after Berkshire Hathaway disclosed its acquisition of nearly 26 million shares of the...
– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in...
Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting PR Newswire TOKYO, May 13, 2024 16 abstracts feature new data and post-hoc analyses of pivotal...
Arm Holdings (NASDAQ:ARM) – SoftBank is collaborating with Arm to develop AI chips, aiming to start mass production in 2025. SoftBank is financially contributing, negotiating with...
Bain Capital (NYSE:BCSF), PowerSchool Holdings (NYSE:PWSC) – Bain Capital is in talks to purchase PowerSchool, an educational software provider, in a private deal that could value the...
Pfizer Inc. (NYSE: PFE) today announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President. Dr. Baum will be a member of Pfizer’s...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.78 | 2.76203966006 | 28.24 | 29.03 | 27.92 | 33560662 | 28.56680105 | CS |
4 | 3.63 | 14.29696731 | 25.39 | 29.03 | 25.2 | 45171038 | 27.26643067 | CS |
12 | 1.27 | 4.57657657658 | 27.75 | 29.03 | 25.2 | 43137500 | 27.09577011 | CS |
26 | -0.95 | -3.16983650317 | 29.97 | 30.75 | 25.2 | 44258013 | 27.61875224 | CS |
52 | -7.87 | -21.3336947682 | 36.89 | 40.365 | 25.2 | 35981826 | 30.48221381 | CS |
156 | -10.98 | -27.45 | 40 | 61.71 | 25.2 | 29798757 | 40.88154966 | CS |
260 | -12.25 | -29.6825781439 | 41.27 | 61.71 | 8 | 29506571 | 39.36316982 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions